表皮生长因子受体酪氨酸激酶抑制剂与肺纤维化的关系
被引量:1
摘要
受体酪氨酸激酶(receptor tyrosine kinases)为一类细胞表面跨膜蛋白,介导细胞外信号向胞内的传导,在细胞增殖、分化和死亡调控过程中起重要作用。
出处
《中华结核和呼吸杂志》
CAS
CSCD
北大核心
2013年第1期53-56,共4页
Chinese Journal of Tuberculosis and Respiratory Diseases
参考文献29
-
1Yarden Y, Sliwkowski MX. Untangling the ErbB signaling network. Nat Rev Mot Cell Biol,2001,2 :127-137. 被引量:1
-
2Sebolt-Leopold JS, English JM. Mechanisms of drug inhibition of signaling molecules. Nature,2006,441:457462. 被引量:1
-
3Klapper LN, Kirschbaum MH, Sela M, et al. Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors. Adv Cancer Res, 2000, 77:25-79. 被引量:1
-
4朱孝峰,刘宗潮,曾益新.酪氨酸激酶受体的信号转导途径与肿瘤治疗[J].药学学报,2002,37(3):229-234. 被引量:15
-
5Olayioye MA, Neve RM, Lane HA, et al. The ErbB signalingnetwork: receptor heterodimerization in development and cancer. EMBO J, 2000, 19:3159-3167. 被引量:1
-
6Selman M, Pardo A. The epithelial/fibroblastic pathway in the pathogenesis of idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol,2003, 29(3 Suppl):$93-$97. 被引量:1
-
7Suzuki H, Aoshiba K, Yokohori N, et al. Epidermal growth factor receptor tyrosine kinase inhibition augments a murine model of pulmonary fibrosis. Cancer Res, 2003, 63:5054-5059. 被引量:1
-
8Rice AB, Moomaw CR, Morqan DL, et al. Specific inhibitors of platelet-derived growth factor or epidermal growth factor receptor tyrosine kinase reduce pulmonary fibrosis in rats. Am J Pathol, 1999, 155:213-221. 被引量:1
-
9Madtes DK, Elston AL, Hackman RC, et al. Transforming growth factor-alpha deficiency reduces pulmonary fibrosis in transgenic mice. Am J Respir Cell MolBiol, 1999, 20:924-934. 被引量:1
-
10Korfhagen TR, Swantz R J, Wert SE, et al. Respiratory epithelial cell expression of human transforming growth factor-alpha induces lung fibrosis in transgenic mice. J Clin Invest, 1994, 93: 1691- 1699. 被引量:1
二级参考文献19
-
1李元桂 蔡向阳 等.肺纤维化大鼠肺内血小板源生长因子受体的表达及黄芪对其的影响[J].同济医科大学学报,2000,29:119-121. 被引量:3
-
2Ashcroft T,Simpson JM,Timbrell V.Simple method of estimating severity of pulmonary fibrosis on a numerical scale[J].J Clin Pathol,1988,41(4):467-470. 被引量:1
-
3Hardie WD,Le Cras TD,Jiang K,et al.Conditional expression of transforming growth factor-alpha in adult mouse lung eauses pulmonary fibrosis[J].Am J Physiol Lung Cell Mol Physiol,2004,286(4):L741-L749. 被引量:1
-
4Madtes DK,Elston AL,Hackman RC,et al.Transforming growth factor-alpha deficiency reduces pulmonary fibrosis in transgenic mice[J].Am J Respir Cell Mlo Biol,1999,20(5):924-934. 被引量:1
-
5Nethery DE,Moore BB,Minowada G,et al.Expression of mutant human epidemud receptor 3 attenuates lung fibrosis and improves survival in mice[J].J Appl Physiol,2005,99(1):298-307. 被引量:1
-
6Rice AB,Moomaw CR,Morgan DL,et al.Specific inhibitors of platelet-derived growth factor or epidermal growth factor receptor tyrosine kinase reduce pulmonary fibrosis in rats[J].Am J Pathol,1999,155(1):213-221. 被引量:1
-
7Gibson S,Tu S,Oyer R,et al.Epidermal growth factor protects epithelial cells against Fas-induced apoptosis.Requirement for Akt activation[J].J Biol Chem,1999,274(25):17612-17618. 被引量:1
-
8Kudoh S,Kato H,Nishiwaki Y,et al.Interstitial lung disease in Japanese patients with lung cancer[J].Am J Respir Crit Care Med,2008,177(12):1348-1357. 被引量:1
-
9Takuno T,Ohe Y,Kusumoto M,et al.Risk factors for interstitial lung disease and predictive factors for tumor respense in patients with advanced non-small cell lung cancer treated with gefitinib[J].Lung Cancer,2004,45(1):93-104. 被引量:1
-
10Raghu G,Nyberg F,Morgan G.The epidemioiogy of interstitial lung disease and its association with lung cancer[J].Br J Cancer,2004,91(Suppl 2):S3-S10. 被引量:1
共引文献29
-
1林嘉颖,吴一龙,杨学宁,陈刚.不同预后肺腺癌患者酪氨酸激酶信号传导通路异常的初步探讨[J].肿瘤防治研究,2005,32(6):339-343.
-
2李文杰,朱孝峰,成志毅.靶向HER2/neu受体酪氨酸激酶抗肿瘤药物研究进展[J].中国药学杂志,2005,40(15):1121-1124. 被引量:1
-
3钟毅,李志裕,尤启冬.血管内皮细胞生长因子受体酪氨酸激酶抑制剂的研究进展[J].中国新药杂志,2006,15(3):181-185. 被引量:8
-
4王德盛,窦科峰,李开宗,宋振顺,赵青川.溶血磷脂酸通过Rho信号转导途径增强肝癌细胞的侵袭转移[J].中华医学杂志,2006,86(6):399-402. 被引量:2
-
5赵晓涛,张正.含Shp-2的酪氨酸蛋白磷酸酶在神经肌肉接头形成中的作用[J].中华医学杂志,2006,86(15):1052-1056. 被引量:2
-
6吴一龙,孙燕.Cancer Management can be Personalized?-Cancer Genomic Research in China[J].The Chinese-German Journal of Clinical Oncology,2006,5(3):156-158.
-
7吴一龙.肺癌多学科综合治疗面临的挑战和机遇[J].中华结核和呼吸杂志,2007,30(2):81-82. 被引量:8
-
8唐蜜,李代强.磷酸化酪氨酸在非小细胞肺癌中的表达及其意义[J].实用预防医学,2007,14(1):30-32. 被引量:1
-
9陈剑鸿,卞修武,姚小红,杨世昕,徐长荣,周向东,平轶芳.诺帝对人恶性胶质瘤细胞U87甲酰化肽受体功能的影响[J].药学学报,2007,42(3):257-262. 被引量:2
-
10茆勇军,李海泓,李剑峰,沈敬山.蛋白酪氨酸激酶信号转导途径与抗肿瘤药物[J].药学学报,2008,43(4):323-334. 被引量:50
同被引文献2
-
1王竞,夏廷毅,王颖杰,李宏奇,李平,王济东,常冬姝,刘丽媛,邸玉鹏,王轩,吴伟章,范乃斌,王佐仁.靶向药物同步个体化放疗治疗晚期/转移性非小细胞肺癌的Ⅱ期临床研究[J].癌症进展,2011,9(1):94-101. 被引量:12
-
2李夏南,朱广迎.EGFR-TKI联合放疗治疗晚期非小细胞肺癌的研究进展[J].中国肺癌杂志,2014,17(4):357-362. 被引量:18
-
1姜杰,欧阳贵平.脲类受体酪氨酸激酶抑制剂的研究进展[J].精细化工中间体,2014,44(5):14-19. 被引量:1
-
2吉非替尼片等3个国产仿制药品上市[J].家庭用药,2017,0(3):51-51.
-
3陈军,朱驹,李卡,宋云龙.血管内皮细胞生长因子受体酪氨酸激酶抑制剂[J].药学进展,2002,26(6):329-333. 被引量:5
-
4唐海涛,陈国广,方正,王玮,韦萍.多靶点受体酪氨酸激酶抑制剂的研究进展[J].中国新药杂志,2009,18(6):502-506. 被引量:10
-
5张莉莉,郭斌.酪氨酸激酶抑制剂的研究进展[J].辽宁中医药大学学报,2009,11(3):71-73. 被引量:1
-
6杨厚赐,徐领城,黄育文.我院2010-2012年靶向抗肿瘤药利用分析[J].中国药房,2014,25(6):512-515. 被引量:6
-
7程刚.靶向治疗药物特罗凯的药代动力学优势[J].中国肺癌杂志,2009,12(6):619-622. 被引量:10
-
8康马飞,阳正煦,刘瑛,孟昭琳,廖漓漓,骆梅青,涂江江.吉非替尼治疗化疗无效的晚期非小细胞肺癌疗效观察[J].中国肺癌杂志,2008,11(2):292-293. 被引量:1
-
9毛小青,马文江.表皮生长因子受体酪氨酸激酶抑制剂致间质性肺炎5例临床分析[J].浙江医学,2010(11):1685-1686. 被引量:1
-
10史爱新,傅得兴.酪氨酸激酶抑制剂的研究进展[J].中国药学杂志,2008,43(14):1045-1049. 被引量:2